Past Event
11 April 2016 - 11 April 2016,
University of Siena, Italy
Organisers: Emanuele Montomoli (University of Siena, Italy), John Wood (NIBSC, UK) , Jackie Katz (CDC, USA), Rebecca Cox (University of Bergen, Norway)
Participants: 65 young scientists, 6 Lars Haaheim scholarships awarded from Nigeria, India, Russia, Poland, Brazil, and Vietnam
Program consisted of the main themes of Societal impact, Global influenza surveillance and prevention, Human and animal influenza, Pathogenesis, Immunology, Vaccines, Antivirals and Regulatory Issues.
| Theme | Session/Title | Name (Affiliations) |
| Day 1: 11 April 2016 | ||
| Influenza virology/immunology | :Welcome, introduction and | Emanuele Montomoli (University of Siena, Italy) John Wood (NIBSC, UK – retired) Lance Jennings (University of Otago, New Zealand) Jackie Katz( CDC, USA) |
| Virus structure, replication, pathogenesis/transmissibility | Wendy Barclay (Imperial College, UK) | |
| Immune response to influenza | Jackie Katz (CDC, USA) | |
| Day 2: 12 April 2018 | ||
| Epidemiology & ecology | Detection methods | Olav Hungnes (Norwegian Institute of Public Health, Norway) |
| Animal influenza, emerging strains, GISAID analysis | Isabella Monne (Istituto Zooprofilattico Sperimentale delle Venezie, Italy) | |
| Pandemic impacts and disease burden: | Jonathan Van Tam (University of Nottingham, UK) | |
| Student presentations | ||
| Prevention and Control | Immune protection correlates | Emanuele Montomoli (University of Siena, Italy) |
| Vaccine virus selection | John Wood (NIBSC, UK) | |
| Vaccine strategies | Lance Jennings (University of Otago, New Zealand) | |
| Day 3: 13 April 2016 | ||
| Vaccines | Inactivated vaccines | Otfried Kistner (Independent Vaccine Expert, Austria) |
| Pandemic and live vaccines | Rebecca Cox (University of Bergen, Norway) | |
| Vaccine effectiveness | Alicia Fry (CDC, USA) | |
| Regulatory challenges | Jerry Weir (FDA, USA) | |
| Neuraminidase role | Ralf Wagner (Paul-Ehrlich Institute, Germany) | |
| Student presentations | ||
| Day 4: 14 April 2016 | ||
| Novel therapeutic strategies | Antiviral effectiveness | Alicia Fry (CDC, USA) |
| Resistance mechanisms | Aeron Hurt (WHO Influenza Collaborating Centre, Australia) | |
| Monoclonal antibodies | Davide Corti (Humabs BioMed SA, Switzerland) | |
| Pandemic preparedness | Pandemic preparedness | Chloe Sellwood (NHS, UK) |
| Pandemic preparedness workshop | Led by Chloe Sellwood (NHS, UK) | |
| Epidemiology and Ecology of Influenza Viruses | Epidemiological influenza surveillance | Mark Miller (NIH, USA) |
| Day 5: 15 April 2016 | ||
| Guest Lectures | Pseudotype immunogenicity testing | Nigel Temperton (The University of Kent at Medway, UK) |
| Universal flu vaccines | Albert Osterhaus (University of Veterinary Medicine Hannover, Germany) | |
| Influenza—past, present & future | Maria Zambon (Public Health England, UK) | |
| Closing session & diploma ceremony | ||